Raniberl en es it fr

Raniberl Brand names, Raniberl Analogs

Raniberl Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Raniberl Chemical_Formula


Raniberl RX_link


Raniberl fda sheet

Raniberl FDA

Raniberl msds (material safety sheet)

Raniberl MSDS

Raniberl Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Raniberl Molecular Weight

314.405 g/mol

Raniberl Melting Point

69-70 oC

Raniberl H2O Solubility

24.7 mg/mL

Raniberl State


Raniberl LogP


Raniberl Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Raniberl Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Raniberl Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Raniberl Absorption

Approximately 50% bioavailability orally.

Raniberl side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Raniberl Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Raniberl Organisms Affected

Humans and other mammals